The impact of proinflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes.
Mireia Ramos-RodríguezHelena Raurell-VilaMaikel L ColliMaria Inês AlvelosMarc Subirana-GranésJonàs Juan-MateuRichard NorrisJean-Valery TuratsinzeErnesto S NakayasuBobbie-Jo M Webb-RobertsonJamie R J InshawPiero MarchettiLorenzo PiemontiManel EstellerJohn A ToddThomas O MetzDécio L EizirikLorenzo PasqualiPublished in: Nature genetics (2019)
The early stages of type 1 diabetes (T1D) are characterized by local autoimmune inflammation and progressive loss of insulin-producing pancreatic β cells. Here we show that exposure to proinflammatory cytokines reveals a marked plasticity of the β-cell regulatory landscape. We expand the repertoire of human islet regulatory elements by mapping stimulus-responsive enhancers linked to changes in the β-cell transcriptome, proteome and three-dimensional chromatin structure. Our data indicate that the β-cell response to cytokines is mediated by the induction of new regulatory regions as well as the activation of primed regulatory elements prebound by islet-specific transcription factors. We find that T1D-associated loci are enriched with newly mapped cis-regulatory regions and identify T1D-associated variants disrupting cytokine-responsive enhancer activity in human β cells. Our study illustrates how β cells respond to a proinflammatory environment and implicate a role for stimulus response islet enhancers in T1D.
Keyphrases
- transcription factor
- single cell
- type diabetes
- induced apoptosis
- cell therapy
- rna seq
- genome wide
- gene expression
- endothelial cells
- cardiovascular disease
- cell cycle arrest
- high resolution
- metabolic syndrome
- mass spectrometry
- dna damage
- drug delivery
- cell death
- bone marrow
- copy number
- data analysis
- induced pluripotent stem cells
- high density
- genome wide identification